While the dollar amount is relatively small, the fact that both a director and CFO are buying shares at current levels may indicate confidence ahead of potential catalysts. Traders should monitor for upcoming clinical updates or financing activity.
Price Chart
Executive Summary
Two corporate insiders at Aldeyra Therapeutics purchased shares in the open market within a 7-day window, totaling $105,100. The purchases were made at prevailing market prices by a director and the principal financial officer, signaling modest confidence in the company's prospects.
Key Financial Metrics
Key Facts
- Director Douglas Richard purchased 70,000 shares for $98,000 on March 19, 2026.
- Principal Financial Officer Michael Alfieri purchased 5,000 shares for $7,100 on March 18, 2026.
- Total open-market purchases amounted to $105,100 across two insiders.
- Total value represents approximately 0.095% of the company's $110M market cap.
Financial Impact
$105,100 in open-market buying by two insiders
Risk Factors
- The total value of purchases is modest (~0.1% of market cap) and may not reflect broad insider conviction.
- No additional public filings or news accompany these trades, limiting context.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-ALDX-1774037884870 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 28d ago | 8-K | $1.32 $0.6412 | ▼ −51.42% | ▼ −52.14% | $0.6412 (−51.42%) |
Aug 16, 2026 10w ago | Institutional Cluster | $1.56 $1.37 | ▲ +12.18% | ▲ +10.20% | $0.6412 (+58.90%) |
Jul 30, 2026 12w ago | 8-K | $1.54 $1.49 | ▼ −3.57% | ▼ −6.56% | $0.6412 (−58.36%) |
Apr 27, 2026 26w ago | DEFA14A | $1.57 $1.78 | ▲ +13.38% | ▲ +7.91% | $0.6412 (−59.16%) |
Apr 20, 2026 27w ago | 8-K | $1.68 $1.60 | ▼ −4.76% | ▼ −9.68% | $0.6412 (−61.83%) |
Mar 18, 2026 31w ago | Insider Cluster | $1.42 $1.80 | ▲ +26.76% | ▲ +20.71% | $0.6412 (−54.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers